Pharmacokinetics and saliva secretion of paracetamol in healthy male Nigerians

West African Journal of Medicine

Volumn 23, Issue 1, 2004, Pages 10-14

  Babalola, Chinedum P ^a   Oladimeji, Festus A ^b   Femi Oyewo, Mbang N ^c  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^c OLABISI ONABANJO UNIVERSITY   (Nigeria)

Author keywords

Paracetamol; Pharmacokinetics; Saliva

Indexed keywords

PARACETAMOL; PFIZERMOL;

ADULT; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SALIVA LEVEL; DRUG USE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MEAN RESIDENCE TIME; NIGERIA; NORMAL HUMAN; RACE DIFFERENCE; SALIVATION; SYMPTOM; VOLUNTEER;

ABSORPTION; ACETAMINOPHEN; ADULT; HUMANS; MALE; NIGERIA; SALIVA;

EID: 3042815795     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Oladimeji FA and Iranloye TA: Survey of analgesic/antipyretic and antimalarial drugs used in Nigeria. Pharmacy World J. 1990; 7:123 - 8.
2. Price-Evans DA: N-Acetyltransferase. Pharmac Ther 1989; 42: 157 - 234.
3. Wilkinson GR, Guengerich FP and Branch RA: Genetic polymorphism of S-mephenytoin hydroxylation. Pharmac Ther 1989; 43: 53 - 76.
4. Eichelbaum M and Gross AS: The genetic polymorphism of debrisoquine/sparteine metabolism - Clinical aspects. Pharmac Ther 1990; 46: 377 - 94.
5. Mucklow JC, Fraser HS, Bulpitt CJ, Kahn C, Mould G and Dollery CT: Environmental factors affecting paracetamol metabolism in London factory and office workers. Br J Clin Pharmac 1980; 10: 67 - 74.
6. Ameer B, Divol M, Abernethy DR, Greenblatt DJ and Shargel L: Absolute and relative bioavailability of oral acetaminophen preparations. J Pharm. Sci 1983; 78: 955 - 8
7. Critchley JAJH, Nimmo GR, Gregson CA, Woolhouse NM and Prescott LF: Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmac 1986; 22: 649 - 57
8. Osborne NJ, Tankin AL and Miners JO: Interethnic differences in drug glucuronidation: A comparison of paracetamol metabolism in Caucasians and Chinese. Br J Pharmac 1991; 32: 765 - 7.
9. Esteban A, Calvo R and Perez-Mateo M: Paracetamol metabolism in two ethnically different spanish populations. Eur. J Drug Metab Pharmacokinet 1996; 21: 233 - 9
10. Yin OQ, Tomlinson B, Chow AH and Chow MS: Pharmacokinetics of acetaminophen in Hong Kong and Chinese subjects. Int J Phar 2001; 222: 308 - 18
11. Prescott LF: Paracetamol overdosage. Drugs 1983; 25: 290 - 314
12. Meredith TJ, Newman B and Goulding R: Paracetamol poisoning in children. Br Med J 1978; 2: 478 - 9.
13. Schiodt FV, Rochling FA, Casey DL and Lee WM: Acetaminophen toxicity in an urban country hospital. N Engl J Med 1997; 337: 1112 - 7
14. Zuidema J, Hold KM, de Boer D and Maes RAA: Saliva as a specimen for therapeutic drug monitoring in pharmacies. Pharm World Sci 1996; 18: 193 - 4.
15. Drobitch RK and Svensson CK: Therapeutic drug monitoring in saliva. An update Clin Pharmacokinet 1992; 23: 365 - 79.
16. Glynn JP and Bastian W: Salivary excretion of paracetamol in man. J Pharm Pharmac 1973; 25: 420 - 1
17. Smith M, Whitfield, E, O'Sullivan G and Reynolds FA: Comparison of serum and saliva paracetamol concentrations. Br J Clin Pharmac 1991; 31: 553-5.
18. Lee HS, Ti TY, Lye WC, Khoo YM and Tan CC: Paracetamol and its metabolites in saliva and plasma in chronic dialysis patients Br. J Clin Pharmac 1996: 41: 41 - 7.
19. Bruner M, Schimiedberger A, Schmid R, Jager D, Piegler E, Eicher HG and Muller M: Direct assessment of peripheral pharmacokinetics in humans: Comparison between cantharides blister fluid, sampling in vivo microdialysis and saliva sampling Br J Clin Pharmac 1998; 46: 425-31.
20. Ameer B, Greenblatt DJ. Divol M, Abernethy DR and Shargel L: High performance liquid chromatographic determination of acetaminophen in plasma, single dose pharmacokinetic studies. J Chromatogr 1981; 443 - 7.
21. Shargel L and Yu ABC: Applied biopharmaceutics and pharmacokinetics 3rd edn. Appleton and Lange, Norwalk C. T. 1993.
22. Coulthard KP, Nielson HW, Schroder M. Cavino A, Matthews NT, Murray RS and Van Der Watt JH: Relative bioavailability and plasma paracetamol profiles of panadol suppositories in children. J Paed Child Hlth 1998; 34:425 - 31.
23. Clarke EGC: Isolation and Identification of Drugs. 2nd edn. The Pharmaceutical Press London. 1986
24. Prescott LF, Sansur M, LevinW and Conney AH: The comparative metabolism of phenacetin and N-acetyl-p-aminophenol in man, with particular reference to effects on the kidney. Clin Pharmacol Ther 1968; 9: 605 - 14.
25. Bartoli A, Xiaodong S, Gatti G, Cipolla G, Marchriselli R and Perucca E: The influence of ethnic factors and gender on CYP1A2 - mediated drug disposition: a comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate. Ther Drug Monit 1996; 18: 586 - 91.
26. Koch-Weser J: Bioavailability of drugs. N Engl J Med 1974; 291: 233 - 7.
27. Babalola CP, Oladimeji FA and Femi-Oyewo MN: Correlation between in vitro and in vivo parameters of some commercial paracetamol tablets. Afr J Med Med Sci 2001; 30: 275 - 80.
28. Posti J: Saliva-plasma drug concentration ratios during absorption: Theoretical considerations and pharmacokinetic implications. Pharm Acta Helv 1982; 57: 83 - 92.